FI944120A7 - Kinoliiniyhdisteet - Google Patents

Kinoliiniyhdisteet Download PDF

Info

Publication number
FI944120A7
FI944120A7 FI944120A FI944120A FI944120A7 FI 944120 A7 FI944120 A7 FI 944120A7 FI 944120 A FI944120 A FI 944120A FI 944120 A FI944120 A FI 944120A FI 944120 A7 FI944120 A7 FI 944120A7
Authority
FI
Finland
Prior art keywords
quinoline compounds
quinoline
compounds
Prior art date
Application number
FI944120A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944120A0 (fi
Inventor
Sprecher Andreas Von
Andreas Beck
Marc Gerspacher
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI944120A0 publication Critical patent/FI944120A0/fi
Publication of FI944120A7 publication Critical patent/FI944120A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI944120A 1993-09-10 1994-09-07 Kinoliiniyhdisteet FI944120A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810645 1993-09-10

Publications (2)

Publication Number Publication Date
FI944120A0 FI944120A0 (fi) 1994-09-07
FI944120A7 true FI944120A7 (fi) 1995-03-11

Family

ID=8215029

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944120A FI944120A7 (fi) 1993-09-10 1994-09-07 Kinoliiniyhdisteet

Country Status (20)

Country Link
US (1) US5508408A (enExample)
JP (1) JP3652721B2 (enExample)
KR (1) KR950008483A (enExample)
CN (1) CN1054845C (enExample)
AT (1) ATE190307T1 (enExample)
AU (1) AU683481B2 (enExample)
CA (1) CA2131644C (enExample)
CZ (1) CZ284006B6 (enExample)
DE (1) DE59409179D1 (enExample)
ES (1) ES2144501T3 (enExample)
FI (1) FI944120A7 (enExample)
HU (1) HUT70556A (enExample)
IL (1) IL110864A0 (enExample)
NO (1) NO301639B1 (enExample)
NZ (1) NZ264420A (enExample)
PH (1) PH31094A (enExample)
PT (1) PT643045E (enExample)
SK (1) SK107394A3 (enExample)
TW (1) TW249802B (enExample)
ZA (1) ZA946957B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ515087A (en) 1999-04-28 2003-11-28 Aventis Pharma Gmbh Tri-aryl acid derivatives as PPAR receptor ligands
IT1320162B1 (it) 2000-02-09 2003-11-18 Rotta Research Lab Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
US6531494B1 (en) * 2001-08-29 2003-03-11 Pharmacia Corporation Gem-substituted αvβ3 antagonists
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109009A (en) * 1985-03-08 1992-04-28 Leo Pharmaceutical Products Ltd. Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4962203A (en) * 1985-06-18 1990-10-09 Merck Frost Canada, Inc. 2-substituted quinolines useful as leukotriene antagonists
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
JPS62145049A (ja) * 1985-12-18 1987-06-29 Mitsubishi Chem Ind Ltd アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
JPS63258854A (ja) * 1987-04-16 1988-10-26 Mitsubishi Kasei Corp カルボキシスチレン誘導体およびそれを有効成分とする薬剤
ES2052825T3 (es) * 1988-07-15 1994-07-16 Hoffmann La Roche Derivados de cicloalquiltiazol.
JPH02275857A (ja) * 1989-01-13 1990-11-09 Yoshitomi Pharmaceut Ind Ltd ピリジン誘導体
CN1078151A (zh) * 1993-01-01 1993-11-10 周礼伯 天然药物成分的蚕药
CN1050999C (zh) * 1993-02-16 2000-04-05 胡祖良 抗病毒性蚕病的蚕药

Also Published As

Publication number Publication date
TW249802B (enExample) 1995-06-21
ATE190307T1 (de) 2000-03-15
CA2131644C (en) 2007-04-24
US5508408A (en) 1996-04-16
AU683481B2 (en) 1997-11-13
CZ218794A3 (en) 1995-03-15
CN1054845C (zh) 2000-07-26
CN1105991A (zh) 1995-08-02
NO943336L (no) 1995-03-13
SK107394A3 (en) 1995-05-10
NZ264420A (en) 1996-06-25
IL110864A0 (en) 1994-11-28
CZ284006B6 (cs) 1998-07-15
ZA946957B (en) 1995-04-18
AU7161794A (en) 1995-03-23
CA2131644A1 (en) 1995-03-11
HUT70556A (en) 1995-10-30
JP3652721B2 (ja) 2005-05-25
HU9402585D0 (en) 1994-11-28
NO301639B1 (no) 1997-11-24
KR950008483A (ko) 1995-04-17
PH31094A (en) 1998-02-05
JPH07179426A (ja) 1995-07-18
DE59409179D1 (de) 2000-04-13
FI944120A0 (fi) 1994-09-07
NO943336D0 (no) 1994-09-09
ES2144501T3 (es) 2000-06-16
PT643045E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
DK0693478T3 (da) Quinolinforbindelser
FI954327L (fi) Atsasykloheksapeptidiyhdisteitä
BR1101108A (pt) Composto
FI945690L (fi) Substituoitu N-piperidino-3-pyratsolikarboksamidi
FI970907L (fi) Pyridatsinokinoliiniyhdisteitä
NO933393D0 (no) Kinolonkarboksylsyrer
FI940154A7 (fi) Substituoidut dialkyylitioeetterit
NO305294B1 (no) R°rhenger
FI954016A7 (fi) Uudet yhdisteet
ATA146094A (de) Windsichter
DK72693D0 (da) Compounds
DE59403503D1 (de) Substituierte 1-Aryltriazolinone
DK124393D0 (da) Compounds
FI956304L (fi) Substituoidut aryltioalkyylitiopyridiinit
ATA194593A (de) Sportschuh
ATA212793A (de) Sportschuh
ATA179094A (de) Kettenschloss
FI954017L (fi) Uudet yhdisteet
BR9405830A (pt) Oxazois substituidos
FI962301A7 (fi) Substituoidut aminoalkyyliaminopyridiinit
FI943637L (fi) Aryylialkoksifenoksi-imidatsoliiniyhdisteitä
DK102693D0 (da) Novel compounds
BR1100774A (pt) Derivado de quinolina
FI932752A0 (fi) Roerformig anordning foer oeppethaollande av urinroeret
FI930372A0 (fi) Anordning foer loesgoering av kaengan fraon en skidbindning

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed